Now showing items 1-6 of 6
Feasibility and willingness-to-pay for integrated community-based tuberculosis testing.
(BMC Infect Dis, 2011-11-02)
BACKGROUND: Community-based screening for TB, combined with HIV and syphilis testing, faces a number of barriers. One significant barrier is the value that target communities place on such screening. METHODS: Integrated ...
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.
(Emerg Infect Dis, 2010-02)
We determined estimated incidence of and risk factors for community-associated Clostridium difficile infection (CA-CDI) among patients treated at 6 North Carolina hospitals. CA-CDI case-patients were defined as adults (>18 ...
Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study.
(PLoS One, 2012)
OBJECTIVE: To determine the feasibility and case detection rate of a geographic information systems (GIS)-based integrated community screening strategy for tuberculosis, syphilis, and human immunodeficiency virus (HIV). ...
Community-based HCV screening: knowledge and attitudes in a high risk urban population.
(BMC Infect Dis, 2014-02-10)
BACKGROUND: In an attempt to curtail the rising morbidity and mortality from undiagnosed HCV (hepatitis C virus) in the United States, screening guidelines have been expanded to high-risk individuals and persons born 1945-1965. ...
Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States.
(AIDS Patient Care STDS, 2010-09)
Knowing one's HIV status is particularly important in the setting of recent tuberculosis (TB) exposure. Blood tests for assessment of tuberculosis infection, such as the QuantiFERON Gold in-tube test (QFT; Cellestis Limited, ...
An integrated alcohol abuse and medical treatment model for patients with hepatitis C.
(Dig Dis Sci, 2012-04)
BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection have high rates of alcohol consumption, which is associated with progression of fibrosis and lower response rates to HCV treatment. AIMS: This prospective ...